Fetal Myelomeningocele Repair: Tribulations and Trials

This enduring material continuing education activity is intended to meet the educational needs and practice skills of physicians, advanced practice nurses, nurses, and other healthcare professionals in the fields of maternal fetal medicine, obstetrics, radiology, genetics, neonatology, pediatric surgery, pediatric cardiology, anesthesiology, pediatrics and family practice.

Among the many issues clinicians face today, staying current with advances in fetal therapy is becoming a major challenge. This enduring material activity will provide participants practical, evidence-based techniques for the management of myelomeningocele (MMC) and enhance clinicians’ skill in diagnosing, counseling and managing pregnancies complicated by MMC. In addition, the course reviews major historical developments in the field of fetal surgery, results from the NIH sponsored “Management of Myelomeningocele” Study (MOMS), and discusses current research as it impacts the future of fetal repair for spina bifida.

These lectures incorporate current, evidence-based diagnostic techniques, defect-specific protocols for fetal repair and surgical management, and cite outcomes from a single center’s long-term experience in fetal therapy. Healthcare professionals who care for these patients need to be aware of the specific criteria to manage these patients and associated outcomes, in order to provide the most up-to-date prognosis and timely access to state-of-the art therapy. The intent is to provide clinicians the knowledge to confidently manage these pregnancies, thereby directly impacting the ultimate outcome for both mother and fetus.

Upon completion of this enduring material, participants will be able to:

  1. Review the natural history of myelomeningocele diagnosed before birth
  2. Discuss the rationale and current indications for fetal myelomeningocele (MMC) repair
  3. Cite results from the "Management of Myelomeningocele Study" (MOMS), and recent outcomes at The Children's Hospital of Philadelphia
  4. List the maternal and neonatal risks and benefits associated with fetal repair of MMC
  5. Discuss current laboratory research and implications for the future of prenatal repair of MMC

AMA Credit Designation Statement

The Children’s Hospital of Philadelphia designates this enduring material for a maximum 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Advanced Practice Nurse and Registered Nurse Participation

Advanced practice providers (APP), nurses and respiratory therapists who complete this enduring material educational activity will need to follow the instructions in the “Method of Participation” section and will be eligible to receive a certificate of completion, which may be used for re-licensure and re-certification. For further information, please contact Kathleen Monforto, PhD, MSN, RN, CPN, Education Nurse Specialist, at monforto@email.chop.edu.